ACRO Biomedical Co., Ltd

ACRO Biomedical was founded in June 2014 in Kaohsiung, Taiwan, by Dr. Dar-Jen Hsieh and a group of scientists and physicians. ACRO Biomedical develops and produces biomaterial medical devices for human tissue engineering and regenerative medicine (TERM). ACRO Biomedical uses its proprietary supercritical CO2 extraction technology to remove cells, fat and non-collagenous proteins from animal tissues, while keeping the undiminished collagen scaffold as the biomaterial for high-end medical devices in the medical regenerative field of wound care, orthopedics, dentistry, ophthalmology, aesthetic microsurgery, cardiovascular and neural surgery, etc

Bone grafts,dental membranes,decellular dermis,dermal fillers,cornea matrix,wound matrix,and collagen

Acro biomedical co., ltd operates in the Biotechnology research industry.

Acro biomedical co., ltd's revenue is 1m - 10m

Acro biomedical co., ltd has 11 - 50 employees.